<DOC>
	<DOC>NCT00086268</DOC>
	<brief_summary>This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIB/IV non-small cell lung cancer. This study will measure the effects of this combination on progression of lung cancer, cancer response to treatments, and development of cancer-related bone lesions.</brief_summary>
	<brief_title>Non-small Cell Lung Cancer Study US75 (Z-PACT)</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<criteria>Male or Female patients at least of 18 years old Patients with diagnosed nonsmall cell lung cancer that cannot be treated by surgery Women must not be pregnant or attempting to become pregnant Able and willing to sign informed consent Patients with cancer that has spread to the bone Patients with cancer that has spread to the brain who are receiving treatment Patients with kidney disease Patients treated with other investigational drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>ZPACT</keyword>
	<keyword>US75</keyword>
	<keyword>Bone Metastases</keyword>
</DOC>